Sterile injectables and ophthalmic manufacturing in Pearl River, NY
RK Pharma manufactures sterile injectables, ophthalmic, and dermal products at scale from a Pearl River facility, with a tech stack anchored in SAP, LIMS, and Oracle—standard pharma manufacturing infrastructure. The hiring mix is heavily manufacturing-focused (16 of 29 active roles) at mid-level seniority, paired with active projects in method validation, stability studies, and cleanroom qualification. Pain points center on GMP compliance maintenance, scaling commercial manufacturing, and data integrity—typical friction for mid-stage contract manufacturers moving from development into sustained production.
Notable leadership hires: Warehouse Lead
RK Pharma operates a state-of-the-art manufacturing facility in Pearl River, New York, specializing in bulk manufacturing and multi-format packaging for sterile injectable, ophthalmic, and dermal products, with end-product release testing capabilities. Solid oral dosage forms are produced through partner manufacturers. The company serves pharmaceutical developers requiring contract manufacturing and quality assurance services. Current operational priorities include method validation, formulation development, stability studies, and microbiology testing for drug product and API release. The organization operates across manufacturing, logistics, engineering, quality, and operations functions.
RK Pharma manufactures bulk formulations and provides multi-format packaging and end-product release testing for sterile injectable, ophthalmic, and dermal products from its Pearl River, NY facility. Solid oral dosage forms are made through partner companies.
Core systems include SAP and Oracle (ERP), LIMS (laboratory information management), GCP, PLCs and HMI (manufacturing automation), SolidWorks and AutoCAD (design), plus standard enterprise tools (Office, Active Directory, Windows Server).
Other companies in the same industry, closest in size